January 2013 • In-Pharma Technologist
Dedicated Facility Injects CRM197 into Conjugate Vaccine Market
January 2013 • Genetic Engineering & Biotechnology News
Pfenex Division Begins Product Capacity Expansion
December 2012 • Genetic Engineering & Biotechnology News
Recombinant Production of Carrier Proteins
November 2012 • BioProcess International
Carrier Protein Outsourcing
October 2012 • NIH Public Access
Conjugating recombinant proteins to Pseudomonas aeruginosa ExoProtein A: a strategy for enhancing immunogenicity of malaria vaccine candidates
October 2012 • Life Science Connect
CEO Insights on Emerging Market Biosimilar Production & Manufacturing Trends
January 2012 • Experimental Neurology
Salmon fibrin treatment of spinal cord injury promotes functional recovery and density of serotonergic innervation
September 2011 • BioProcess International Vaccine Supplement
Pseudomonas fluorescens Expression Technology for Subunit Vaccine Production and Development
July 2011 • Genetic Engineering & Biotechnology News
Achieving Optimal Expression for Fabs
July 2011 • Genetic Engineering & Biotechnology News
Nudging Difficult-to-Express Proteins- Emerging Solutions Aim to Bring Challenging Targets Under Control
January 2013 • Genetic Engineering & Biotechnology News
Pfenex Division Begins Product Capacity Expansion
December 2012 • Genetic Engineering & Biotechnology News
Recombinant Production of Carrier Proteins
November 2012 • BioProcess International
Carrier Protein Outsourcing
October 2012 • NIH Public Access
Conjugating recombinant proteins to Pseudomonas aeruginosa ExoProtein A: a strategy for enhancing immunogenicity of malaria vaccine candidates
October 2012 • Life Science Connect
CEO Insights on Emerging Market Biosimilar Production & Manufacturing Trends
January 2012 • Experimental Neurology
Salmon fibrin treatment of spinal cord injury promotes functional recovery and density of serotonergic innervation
September 2011 • BioProcess International Vaccine Supplement
Pseudomonas fluorescens Expression Technology for Subunit Vaccine Production and Development
July 2011 • Genetic Engineering & Biotechnology News
Achieving Optimal Expression for Fabs
July 2011 • Genetic Engineering & Biotechnology News
Nudging Difficult-to-Express Proteins- Emerging Solutions Aim to Bring Challenging Targets Under Control
June 2011 • Innovations in Pharmaceutical Technology
A Toolbox for Protein Expression Scientists
June 2011 • Life Science Leader
Maximizing Pipeline Value and Operational Efficiency through High Throughput Protein Expression
November, 2010 • Bioprocess International
Modeling BioProcess Costs, Process Economic Benefits of Expression Technology based on Pseudomonas fluorescens
August, 2010 • Next Generation Pharma
The Real Value Driver
June, 2010 • Genetic Engineering & Biotechnology News
Pharmaceuticals: Cash Injection for Biologic Drugs
February • Chemical Week News
Pharmaceuticals: Cash Injection for Biologic Drugs
January • BioCentury, The Bernstein Report on BioBusines
Pfenex: Pfaster Protein Production
Case Studies and Presentations
November 2012
Salmon Fibrin Treatment Promotes Lesion Cavity Repair After Spinal Injury in Rats
December 2011
InfoGraphic: Malaria, the Possible Eradication of the World's Greatest Killer
By Assay Depot
September 2011
Get There Faster With Pfenex
Why Sourcing Makes More Sense
May 2011, PEGS
Boehringer Ingelheim Presents- Expression of an Antibody Fragment Utlizing the Pfēnex Expression Technology™ Platform
March 2011, ACS BIOT
Expeditious strain and fermentation development for quality recombinant protein production in Pseudomonas fluorescens
March 2011, ACS BIOT
Purification of Vaccine Antigens & Carriers Expressed in Pseudomonas fluorescens
January 2011, PepTalk
Rapid Production of High Quality Protein Enabled by Pfēnex Expression Technology™
January 2011, PepTalk
Soluble Periplasmic Production of Human Granulocyte Colony-Stimulating Factor (G-CSF) in Pseudomonas fluorescens
Advanced Search
|
